MISO has the mission to provide tumor-representative solutions to scientists in academia, industry and to physicians to better predict cancer treatment effects and make discoveries that impact patients' lives
Thomas Gervais, Co-Founder - CTO
Thomas is MISO technology driver. The results of his research at Polytechnique Montreal/CRCHUM in microfluidics and bioengineering are MISO core value.
Thomas did his PhD at MIT where he gained unrivaled knowledge and expertise in microfluidics. Loved by everyone who surround him, Tom listens to biologists and physicians’ needs and can easily integrate his understandings into innovative solutions.
Étienne Laurent, Co-Founder - CEO
Étienne is an Electrical/Biomedical engineer and is a master candidate in Technology Management, he is the one behind MISO business plan and its execution.
He fell in love with microfluidics during his bachelor degree at Polytechnique Montreal. Since then, he always wanted to be part of the Lab-on-a-Chip’s emancipation.
Étienne admires great scientists. Through MISO, he wants to help them turn discoveries into real impact on patients’ lives.
Philip Wong, Co-Founder - CMO
Philip is a Radio-Oncologist at the CHUM. His research interests are 1) in the development of prognostic and predictive markers of sensitivity to radiotherapy and 2) new strategies in combining radiation with molecular agents to improve the efficacy of radiotherapy or to better protect normal tissue from treatment toxicities.
His research focuses primarily on sarcoma and palliative medicine clinic. Through MISO, Philip wants to accelerate the time it takes to bring innovation to patients.
MISO is based in Montreal within its lively startup ecosystem and academia. For any questions or requests, if you wonder how you can integrate 3D cell culture into your project, please feel free to get in touch with us.